TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15291711

Group type: EXPERIMENTAL
Intervention: Health Education Program (HEP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0
Study: 11728623

Group type: EXPERIMENTAL
Intervention: Randomization procedures implemented in clinical trials
Number of subjects: 0
Study: 9160916

Group type: EXPERIMENTAL
Intervention: Cimetidine (local treatment for 4 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (normal subjects)
Number of subjects: 0
Study: 8105773

Group type: EXPERIMENTAL
Intervention: Brimonidine administered before and after the procedure
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Brimonidine administered before the procedure
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Brimonidine administered after the procedure
Number of subjects: 248

Group type: COMPARATOR
Intervention: Vehicle administered before and after the procedure
Number of subjects: 248
Study: 3114306

Group type: EXPERIMENTAL
Intervention: Lovastatin (mevinolin)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Neomycin
Number of subjects: 16
Study: 29314350

Group type: EXPERIMENTAL
Intervention: Web-based cognitive rehabilitation intervention (4-week online program)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Non-cancer treatment group (4-week online program)
Number of subjects: 51
Study: 26774112

Group type: EXPERIMENTAL
Intervention: Foley catheter with 80 mL
Number of subjects: 154

Group type: COMPARATOR
Intervention: Foley catheter with 30 mL
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Both groups (80 mL and 30 mL)
Number of subjects: 154
Study: 24888209

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 38

Group type: COMPARATOR
Intervention: Assessment control
Number of subjects: 38
Study: 21846427

Group type: EXPERIMENTAL
Intervention: Coping with depression course
Number of subjects: 101
Study: 20160156

Group type: EXPERIMENTAL
Intervention: Partial-block crossover design for dutasteride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulations of the partial-block crossover design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Previous single-dose dutasteride studies
Number of subjects: 0
Study: 18571226

Group type: EXPERIMENTAL
Intervention: Financial incentives of $50 plus up to $25 more per week based on aerobic minutes (10+ minutes of continuous walking or jogging)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Fixed payment of $75
Number of subjects: 51
Study: 16669843

Group type: EXPERIMENTAL
Intervention: β‐adrenoceptor blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thrombolytic agents
Number of subjects: 0
Study: 14636909

Group type: EXPERIMENTAL
Intervention: Cilostazol 100 mg twice daily for 6 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10954953

Group type: EXPERIMENTAL
Intervention: Sumatriptan nasal spray (20 mg)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Dihydroergotamine nasal spray (1 mg plus optional 1 mg)
Number of subjects: 368
Study: 8623945

Group type: EXPERIMENTAL
Intervention: Group A: 20 mL of propofol alone in a commercial preparation (Diprivan(R) with 10 mL of saline)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Group C: 20 mL of propofol and 10 mL of LCT fat emulsion
Number of subjects: 36

Group type: COMPARATOR
Intervention: Group B: 20 mL of propofol with 5 mL of long‐chain triglyceride (LCT) fat emulsion and 5 mL of saline
Number of subjects: 36
Study: 1422747

Group type: EXPERIMENTAL
Intervention: Stripping of the long saphenous vein (LSV) to the upper calf (n = 49)
Number of subjects: 69

Group type: COMPARATOR
Intervention: SFJ ligation alone (n = 56)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Stripping of the long saphenous vein (LSV) to the upper calf
Number of subjects: 69

Group type: COMPARATOR
Intervention: SFJ ligation alone
Number of subjects: 69
Study: 6378105

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 31064379

Group type: EXPERIMENTAL
Intervention: PThC (Critical Inspiratory Pressure)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 60% of MIP (Maximal Inspiratory Pressure)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham (SG)
Number of subjects: 30
Study: 29373753

Group type: EXPERIMENTAL
Intervention: Dicer partner protein Loquacious‐PB (Loqs‐PB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Base-mismatch in the pre-miRNA stem
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dram-seq method
Number of subjects: 0
Study: 27534645

Group type: EXPERIMENTAL
Intervention: Vitamin B‐12 status (total vitamin B‐12, holotranscobalamin, cB‐12)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Vitamin B‐12 status
Number of subjects: 201
Study: 24629718

Group type: EXPERIMENTAL
Intervention: Mindfulness eating and yoga exercise
Number of subjects: 0
Study: 23106878

Group type: EXPERIMENTAL
Intervention: Oral testosterone undecanoate (TU) capsules, 120 - 160 mg daily for 6 months
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Oral testosterone undecanoate (TU) capsules
Number of subjects: 160

Group type: COMPARATOR
Intervention: Vitamin E/C capsules (control)
Number of subjects: 160
Study: 19811509

Group type: EXPERIMENTAL
Intervention: 3T MRI without o-CRH stimulation
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 3T MRI with o-CRH stimulation
Number of subjects: 21

Group type: COMPARATOR
Intervention: 3T MRI
Number of subjects: 21

Group type: COMPARATOR
Intervention: 1.5T MRI
Number of subjects: 21
Study: 18626271

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Low dose (1.0 mg/kg) MDMA
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High dose (1.6 mg/kg) MDMA
Number of subjects: 8
Study: 16143742

Group type: EXPERIMENTAL
Intervention: Peer counseling group (PC)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 162
Study: 11791092

Group type: EXPERIMENTAL
Intervention: Trovafloxacin
Number of subjects: 311

Group type: COMPARATOR
Intervention: Ceftriaxone with or without vancomycin
Number of subjects: 311
Study: 10220130

Group type: EXPERIMENTAL
Intervention: New antipsychotics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference antipsychotic
Number of subjects: 0
Study: 7794082

Group type: EXPERIMENTAL
Intervention: Surgical resection
Number of subjects: 50

Group type: COMPARATOR
Intervention: Radiation therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Operative palliation
Number of subjects: 50
Study: 2064541

Group type: EXPERIMENTAL
Intervention: Sexually explicit videotape (experimental group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonerotic videotape (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sexually explicit videotape (both groups after 90 minutes)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (across the session)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (correlation analysis)
Number of subjects: 0
Study: 7140708

Group type: EXPERIMENTAL
Intervention: 0.25 ppm SO2
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.50 ppm SO2
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0 ppm SO2 (Control)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 24
Study: 31554388

Group type: EXPERIMENTAL
Intervention: 14-day high dose PPI-bismuth-containing quadruple therapy with probiotics (37.5 mg Lactobacillus reuteri, Biogaia® in tablet twice daily)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 7-day high dose PPI-bismuth-containing quadruple therapy with probiotics
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 14-day high dose PPI-bismuth-containing quadruple therapy with probiotics
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Probiotics group
Number of subjects: 100
Study: 29143416

Group type: EXPERIMENTAL
Intervention: Aliskiren
Number of subjects: 1306
Study: 27858873

Group type: EXPERIMENTAL
Intervention: Chemotherapy + Dexrazoxane (Chemo + DRZ)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Chemotherapy alone (Chemo)
Number of subjects: 110
Study: 25213806

Group type: EXPERIMENTAL
Intervention: Preventive consultations with a general practitioner
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Responders after telephone reminding
Number of subjects: 364

Group type: COMPARATOR
Intervention: Primary responders
Number of subjects: 364
Study: 23140338

Group type: EXPERIMENTAL
Intervention: Short theory of mind intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 100
Study: 20298496

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week (eow)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg weekly
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups (adalimumab eow, adalimumab weekly, placebo)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 0
Study: 18205098

Group type: EXPERIMENTAL
Intervention: Aliskiren (150 mg titrated to 300 mg after four weeks)
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Ramipril (5 mg titrated to 10 mg)
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Aliskiren and Ramipril combination
Number of subjects: 837
Study: 15656327

Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 11802936

Group type: EXPERIMENTAL
Intervention: Intrapleural urokinase
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 81
Study: 9543117

Group type: EXPERIMENTAL
Intervention: Calcium supplement (714 mg Ca/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (total Ca intake, 288 +/- 128 mg/day)
Number of subjects: 60
Study: 7850816

Group type: EXPERIMENTAL
Intervention: Renal transplantation (RT) with blood pressure decrease (group I)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Renal transplantation (RT) with blood pressure increase (group II)
Number of subjects: 30
Study: 2844981

Group type: EXPERIMENTAL
Intervention: Immediate daily ganciclovir maintenance therapy
Number of subjects: 11

Group type: COMPARATOR
Intervention: Deferred maintenance therapy
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Deferred maintenance therapy after crossover
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Maintenance therapy
Number of subjects: 11

Group type: COMPARATOR
Intervention: Off maintenance therapy
Number of subjects: 11
Study: 31590179

Group type: COMPARATOR
Intervention: Naltrexone (NTX; 50 mg/day) + placebo memantine
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX; 50 mg/day) + memantine (MEM; 20 mg/day)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Naltrexone (NTX; 50 mg/day) alone
Number of subjects: 56
Study: 30954042

Group type: EXPERIMENTAL
Intervention: MOB-ML method
Number of subjects: 7211
Study: 28700036

Group type: EXPERIMENTAL
Intervention: Standard cognitive training program
Number of subjects: 6

Group type: COMPARATOR
Intervention: Controlled placebo condition
Number of subjects: 6
Study: 25440636

Group type: EXPERIMENTAL
Intervention: Respiratory rate of 15 cycles/min with low-tidal-volume (5 mL/kg) and two-lung ventilation
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Respiratory rate of 18 cycles/min with low-tidal-volume (5 mL/kg) and two-lung ventilation
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Respiratory rate of 22 cycles/min with low-tidal-volume (5 mL/kg) and two-lung ventilation
Number of subjects: 48
Study: 24377221

Group type: EXPERIMENTAL
Intervention: Intermittent wave (IW) electroacupuncture combined with rehabilitation therapy
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Disperse-dense wave (DW) electroacupuncture combined with rehabilitation therapy
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Continuous wave (CW) electroacupuncture combined with rehabilitation therapy
Number of subjects: 75
Study: 21278214

Group type: EXPERIMENTAL
Intervention: MRKAd5 HIV-1 gag/pol/nef vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HLA-B alleles associated with HIV-1 control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Host immunogenetic background
Number of subjects: 0
Study: 19917887

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD) therapy
Number of subjects: 2521

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 2521

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2521
Study: 15542278

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibition
Number of subjects: 234

Group type: COMPARATOR
Intervention: Angiotensin II antagonism
Number of subjects: 234
Study: 10077713

Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 40

Group type: COMPARATOR
Intervention: Needling at non-acupuncture points (Control)
Number of subjects: 40
Study: 7672690

Group type: EXPERIMENTAL
Intervention: Muscle training with visual biofeedback (EMG record visible to the patient)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Muscle training without visual biofeedback
Number of subjects: 0
Study: 2258782

Group type: EXPERIMENTAL
Intervention: Betaxolol
Number of subjects: 17

Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 17
Study: 7422170

Group type: EXPERIMENTAL
Intervention: ethinyl estradiol, 50 microgram per day
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: levonorgestrel, 250 microgram per day
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: combination of ethinyl estradiol and levonorgestrel (Nordiol)
Number of subjects: 49

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 49
Study: 30565715

Group type: EXPERIMENTAL
Intervention: 4% CHx‐based product applied with scrub technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4% CHx‐based product applied with rub technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CHx/alcohol‐combination (1% CHx and 61% ethanol) applied with rub technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sole ABR (80% ethanol) applied with rub technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: CHx‐scrub technique
Number of subjects: 0
Study: 28548210

Group type: EXPERIMENTAL
Intervention: Xenogeneic collagen matrix (XCM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Connective tissue graft (CTG)
Number of subjects: 60
Study: 26156568

Group type: EXPERIMENTAL
Intervention: YouTube
Number of subjects: 0

Group type: COMPARATOR
Intervention: Twitter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Facebook
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blogs
Number of subjects: 0
Study: 24598495

Group type: EXPERIMENTAL
Intervention: Semilunar coronally positioned flap technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Coronally advanced flap technique
Number of subjects: 20
Study: 21755358

Group type: EXPERIMENTAL
Intervention: Lengthening contractions (LC)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Shortening contractions (SC)
Number of subjects: 9
Study: 19615653

Group type: EXPERIMENTAL
Intervention: Simple loop suture
Number of subjects: 15

Group type: COMPARATOR
Intervention: Anchor suture
Number of subjects: 15

Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 15
Study: 17615800

Group type: EXPERIMENTAL
Intervention: Subcutaneous dalteparin (5000 IU) once daily
Number of subjects: 3706

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3706
Study: 15543329

Group type: EXPERIMENTAL
Intervention: Vitamin K(1)-containing multivitamin (25 mcg daily for 4 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vitamin K(1)-free multivitamin (4 weeks)
Number of subjects: 16
Study: 11994558

Group type: EXPERIMENTAL
Intervention: Combination drug therapy with glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytics
Number of subjects: 0
Study: 9685777

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics during intracranial pressure monitoring
Number of subjects: 30

Group type: COMPARATOR
Intervention: No prophylactic antibiotics and no intracranial pressure monitoring
Number of subjects: 30
Study: 7925510

Group type: EXPERIMENTAL
Intervention: Captopril 6.25 mg, titrated to 25 mg t.i.d.
Number of subjects: 298

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study: 2810673

Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 22

Group type: COMPARATOR
Intervention: Lovastatin and Gemfibrozil
Number of subjects: 22
Study: 31089256

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 189
Study: 27569255

Group type: EXPERIMENTAL
Intervention: Vitamin D + B vitamins
Number of subjects: 52

Group type: COMPARATOR
Intervention: Vitamin D
Number of subjects: 52
Study: 25973809

Group type: EXPERIMENTAL
Intervention: Safe Touches intervention
Number of subjects: 492

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 492
Study: 24716248

Group type: EXPERIMENTAL
Intervention: Conventional Restorative Treatment (CRT)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Ultra-Conservative Treatment (UCT)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 302
Study: 21301356

Group type: EXPERIMENTAL
Intervention: C-D score method
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Constipation severity by VAS
Number of subjects: 84
Study: 19299409

Group type: EXPERIMENTAL
Intervention: Personally tailored feedback based on lung functioning, CO exposure, and smoking-related health conditions
Number of subjects: 536

Group type: COMPARATOR
Intervention: Generic information about the risks of smoking and personalized counseling based on diet, body mass index, and physical activity
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Experimental group with impaired lung functioning
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Experimental group without impaired lung functioning
Number of subjects: 536
Study: 18174971

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15895759

Group type: EXPERIMENTAL
Intervention: Warfarin plus aspirin (WA) (n = 418)
Number of subjects: 831

Group type: COMPARATOR
Intervention: Aspirin alone (n = 413)
Number of subjects: 831
Study: 12238845

Group type: EXPERIMENTAL
Intervention: Capiox poly(2‐methoxyethylacrylate) coated SX18R oxygenators with noncoated circuits
Number of subjects: 60

Group type: COMPARATOR
Intervention: Noncoated oxygenator fibers
Number of subjects: 60
Study: 9718228

Group type: EXPERIMENTAL
Intervention: Metrifonate 40/50 mg
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Metrifonate 60/80 mg
Number of subjects: 605

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 605
Study: 7863722

Group type: EXPERIMENTAL
Intervention: Chewable pyrantel pamoate tablets (swallow whole)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chewable pyrantel pamoate tablets (chew and swallow)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chewable pyrantel pamoate tablets (pulverized)
Number of subjects: 0
Study: 2644954

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Surgery and Radiation Therapy
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 266
Study: 235144

Group type: EXPERIMENTAL
Intervention: Maintenance amitriptyline for eight months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weekly psychotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Once monthly psychotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Double-blind withdrawal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Overt withdrawal
Number of subjects: 0
Study: 31197436

Group type: EXPERIMENTAL
Intervention: 2 mg prazosin
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 28257875

Group type: EXPERIMENTAL
Intervention: Combined WM, IC, and neurofeedback training using Focus Pocus software, 25 sessions over 7 to 8 weeks
Number of subjects: 85

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 85
Study: 26409698

Group type: EXPERIMENTAL
Intervention: mCIMT + TR
Number of subjects: 18

Group type: COMPARATOR
Intervention: mCIMT
Number of subjects: 18
Study: 24129363

Group type: EXPERIMENTAL
Intervention: 100 g-organic naked oat with whole germ group (ONOG)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: 50 g-organic naked oat with whole germ group (ONOG)
Number of subjects: 260

Group type: COMPARATOR
Intervention: diet group (systematic diet plans and intensive education)
Number of subjects: 260

Group type: COMPARATOR
Intervention: usual care group (control group, only basic health advice)
Number of subjects: 260
Study: 21693504

Group type: EXPERIMENTAL
Intervention: Reduction in systolic blood pressure (SBP) during treatment
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure reduction (relative change > median)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure reduction
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: No systolic blood pressure reduction
Number of subjects: 386
Study: 18274852

Group type: EXPERIMENTAL
Intervention: Finalized questionnaire administered to patients
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Finalized questionnaire
Number of subjects: 369
Study: 17123908

Group type: EXPERIMENTAL
Intervention: Platelet pellet/guided tissue regeneration (PP/GTR)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Bioactive glass/guided tissue regeneration (BG/GTR)
Number of subjects: 15
Study: 15580194

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment (1mg/m2/day)
Number of subjects: 29
Study: 11531901

Group type: EXPERIMENTAL
Intervention: Sferics measurement (low frequency, low intensity electromagnetic pulses)
Number of subjects: 21
Study: 9201877

Group type: EXPERIMENTAL
Intervention: Doppler assessment of uterine and uteroplacental circulation
Number of subjects: 175
Study: 8273900

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 132

Group type: COMPARATOR
Intervention: Intravenous patient-controlled analgesia (IVPCA) with 10 mg pethidine
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Intravenous patient-controlled analgesia (IVPCA) with 20 mg pethidine
Number of subjects: 132